Pfizer and BioNTech On Tuesday Received U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced Tuesday that the U.S.
Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines?
Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr.
How Much Did US Government Spend On mRNA Vaccine Technology Before And During The Pandemic? The Number Can Be Surprising
The U.S. government invested at least $31.9 billion to develop, produce, and purchase mRNA COVID-19 vaccines, including sizeable…
Pfizer And BioNTech Begin Phase 1/2 Trial Of First-In-Class mRNA-Based Shingles Vaccine Program
https://investors.biontech.de/de/news-releases/news-release-details/pfizer-und-biontech-beginnen-phase-12-studie-mit-erstem-mrna
Goldman Sachs Maintains Neutral on BioNTech, Lowers Price Target to $156
Goldman Sachs analyst Chris Shibutani maintains BioNTech (NASDAQ:BNTX) with a Neutral and lowers the price target from $177 to $156.
‘U.K. Lawmakers Urge Pfizer Not To Raise The Price Of Its Covid-19 Vaccine’ – Stat News
https://www.statnews.com/pharmalot/2023/01/30/pfizer-covid19-vaccine-price-hike-uk/
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020.
Since then, the virus has caused more than 6.8 million deaths.